All In Biotech

Drug Trial Radar · NCT05929066

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 2,335 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,335

Actual

Start

Jul 10, 2023

Primary completion

Apr 6, 2026

Study completion Apr 30, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits. Addendum (2) is optional and available to approximately 500 participants to continue treatment with retatrutide for up to an additional 24 weeks.

Conditions

  • Obesity
  • Overweight
  • Osteoarthritis, Knee
  • Obstructive Sleep Apnea

Interventions

  • RetatrutideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body WeightTime frame: Baseline, Week 80
  2. Change from Baseline in Apnea-Hypopnea Index (AHI) Events Per Hour for GSA1 SubsetTime frame: Baseline, Week 80
  3. Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score for GOA1 SubsetTime frame: Baseline, Week 80
  4. Percent Change from Baseline in Body Weight in Participants in Extension SubsetTime frame: Baseline, Week 104

Locations

134 sites in 12 countries. Site status is shown where the registry gives one.

  • Central Phoenix Medical Clinic

    Phoenix, Arizona

  • Arizona Research Center

    Phoenix, Arizona

  • Medical Investigations

    Little Rock, Arkansas

  • Neuro-Pain Medical Center

    Fresno, California

  • Valley Research

    Fresno, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Yale University School of Medicine

    New Haven, Connecticut

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Teradan Clinical Trials, LLC

    Brandon, Florida

  • Suncoast Research Group

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • Clinical Neuroscience Solutions

    Orlando, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • NeuroTrials Research Inc

    Atlanta, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Northwestern University

    Chicago, Illinois

  • Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative

    Springfield, Illinois

  • Brengle Family Medicine

    Indianapolis, Indiana

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • MedVadis Research Corporation

    Waltham, Massachusetts

  • Great Lakes Research Group, Inc.

    Bay City, Michigan

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Clinvest Research LLC

    Springfield, Missouri

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • Rochester Clinical Research, LLC

    Rochester, New York

  • Carteret Medical Group

    Morehead City, North Carolina

  • Trial Management Associates - Wilmington - Floral Parkway

    Wilmington, North Carolina

  • Lillestol Research

    Fargo, North Dakota

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania

  • Tribe Clinical Research, LLC

    Greenville, South Carolina

  • Tribe Clinical Research - Spartanburg

    Spartanburg, South Carolina

  • Vanderbilt Health One Hundred Oaks

    Nashville, Tennessee

  • FutureSearch Trials of Neurology

    Austin, Texas

  • Juno Research

    Houston, Texas

  • Advanced Research Institute

    Ogden, Utah

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Rainier Clinical Research Center

    Renton, Washington

  • Emeritus Research

    Botany, New South Wales, Australia

Showing 40 of 134 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.